NEW
YORK, July 22, 2024 /PRNewswire/
-- Hospital for Special Surgery (HSS), the world's leading
academic medical center focused on musculoskeletal health, today
announced the appointments of Sheeraz
Qureshi, MD, MBA, as Chief Medical Officer of HSS Florida
and David Backstein, MD, as Medical
Director of HSS at NCH. Dr. Qureshi succeeds Douglas E. Padgett, MD, who was appointed
Surgeon-in-Chief and Medical Director of the HSS enterprise in
September. Dr. Backstein succeeds David L.
Helfet, MD, who will continue to serve as Founding Medical
Director of HSS at NCH. All three appointments are effective
immediately.
![HSS Logo (PRNewsfoto/Hospital for Special Surgery) HSS Logo (PRNewsfoto/Hospital for Special Surgery)](https://mma.prnewswire.com/media/465239/HSS_Logo.jpg)
As Co-Chief of HSS Spine and holder of the Patty and Jay Baker
Chair in Minimally Invasive Spine Surgery, Dr. Qureshi is an
internationally recognized leader in the field of minimally
invasive and motion-sparing spine surgery. In his expanded role as
Chief Medical Officer, Dr. Qureshi will oversee clinical operations
and quality across all HSS Florida locations and for HSS at NCH. He
will also partner with HSS Florida CEO Tara
McCoy to make HSS care more accessible to more people across
the state of Florida and cultivate
relationships with industry, employers and other strategic
partners. Dr. Qureshi will maintain his leadership role and
clinical practice at the HSS Main Campus in New York.
"I am thrilled to welcome Dr. Qureshi to our team. He brings a
wealth of clinical experience and proven leadership history to HSS
Florida," said Ms. McCoy. "I'm looking forward to collaborating
with him to expand high-quality leading-edge treatment options to
patients across the state."
"I am honored and deeply grateful for the opportunity to
collaborate with a dynamic Florida
clinical team and staff who are dedicated to improving orthopedic
care in the communities we serve," Dr. Qureshi said. "Together, we
will continue to provide more people with the high-quality
orthopedic care they have come to expect from HSS."
David Backstein, MD, is
Appointed Medical Director of HSS at NCH
Dr. Backstein is an orthopedic surgeon specializing in
primary and revision total knee replacement and primary hip
replacement. He has special expertise in the use of minimally
invasive and robotic techniques in joint replacement surgeries. Dr.
Backstein, who joined HSS at NCH earlier this year from the
University of Toronto where he led the
division of orthopedics at Mount Sinai Hospital, is the recipient
of numerous awards for clinical research and has published more
than 200 papers in peer-reviewed journals. He regularly presents
his work at conferences all over the country and around the
globe.
Dr. Backstein succeeds Dr. Helfet, who has helped to guide the
first year of the HSS at NCH collaboration. As Founding Medical
Director, Dr. Helfet will continue to serve the Naples community, providing education on HSS
and the new HSS at NCH Musculoskeletal Center as well as partnering
with the HSS and NCH philanthropy teams. Additionally, he will
serve as a conduit between HSS at NCH and HSS's main campus in
New York City, helping to foster
increased clinical alignment.
"Dr. Helfet's expertise has been paramount in establishing the
musculoskeletal center and the Orthopedic Service, and his
collaboration with Dr. Backstein will ensure that our world-class
orthopedic care and outstanding patient experience are seamless for
communities in southwest Florida,"
said Dr. Padgett. "Dr. Backstein's leadership complements our
dedication to excellence and to move healthcare forward for the
residents of Florida and
beyond."
"We are excited about these additions to leadership. We continue
to strengthen our collaboration while enhancing our ability to
deliver outstanding orthopedic health services," said Paul Hiltz, President and CEO, NCH. "This marks
an exciting new chapter for HSS at NCH."
"Fostering a stronger collaboration between HSS and NCH
clinicians, researchers, and industry partners to find clinical
solutions for patients in our Florida communities will be a primary focus
for me in my new role," said Dr. Backstein. "I'm looking forward to
working with Dr. Helfet and the greater care team to bridge the gap
between clinical need and outcomes."
The HSS at NCH musculoskeletal center, now under development,
spans more than 80,000 square feet and will be the centerpiece in
the HSS at NCH collaboration to elevate orthopedic care in
Naples and Southwest Florida. The facility will offer
outpatient and inpatient orthopedic services, including an
ambulatory surgery center, imaging, and rehabilitation, and will be
jointly operated by HSS and NCH. The HSS at NCH facility is
scheduled to open in 2025.
About HSS
HSS is the world's leading academic medical center focused on
musculoskeletal health. At its core is Hospital for Special
Surgery, nationally ranked No. 1 in orthopedics (for the 15th
consecutive year), No. 3 in rheumatology by U.S. News & World
Report (2024-2025), and the best pediatric orthopedic hospital in
NY, NJ and CT by U.S. News & World Report "Best Children's
Hospitals" list (2023-2024). In a survey of medical professionals
in more than 20 countries by Newsweek, HSS is ranked world #1 in
orthopedics for a fourth consecutive year (2023). Founded in 1863,
the Hospital has the lowest readmission rates in the nation for
orthopedics, and among the lowest infection and complication rates.
HSS was the first in New York
State to receive Magnet Recognition for Excellence in
Nursing Service from the American Nurses Credentialing Center five
consecutive times. An affiliate of Weill Cornell Medical College,
HSS has a main campus in New York
City and facilities in New
Jersey, Connecticut and in
the Long Island and Westchester County regions of New York State, as well as in Florida. In addition to patient care, HSS
leads the field in research, innovation and education. The HSS
Research Institute comprises 20 laboratories and 300 staff members
focused on leading the advancement of musculoskeletal health
through prevention of degeneration, tissue repair and tissue
regeneration. In addition, more than 200 HSS clinical investigators
are working to improve patient outcomes through better ways to
prevent, diagnose, and treat orthopedic, rheumatic and
musculoskeletal diseases. The HSS Innovation Institute works to
realize the potential of new drugs, therapeutics and devices. The
HSS Education Institute is a trusted leader in advancing
musculoskeletal knowledge and research for physicians, nurses,
allied health professionals, academic trainees, and consumers in
more than 165 countries. The institution is collaborating with
medical centers and other organizations to advance the quality and
value of musculoskeletal care and to make world-class HSS care more
widely accessible nationally and internationally. www.hss.edu.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/sheeraz-qureshi-md-mba-succeeds-douglas-e-padgett-md-as-chief-medical-officer-of-hss-florida-david-backstein-md-named-medical-director-of-hss-at-nch-302202056.html
SOURCE Hospital for Special Surgery